Boquete A L, Vargas Roig L, López G A, Gude R, Binda M M, González A D, Ciocca D R, Bonfil R D
Laboratory of Fundación de Investigación del Cáncer at CEFYBO, Serrano 669, (C1414DEM), Buenos Aires, Argentina.
Cancer Lett. 2001 Apr 10;165(1):111-6. doi: 10.1016/s0304-3835(01)00410-4.
Chemosensitivity of the human colon carcinoma HCT-15 cell line to 4'-epidoxorubicin proved to be 100-fold higher than that of its variant HCT-15 EDR. Confocal scanning microscopy showed significant less drug accumulation in HCT-15 EDR. A 2-fold increase in hsp27 expression was found in HCT-15 EDR, with no alteration in hsp70. The expression of the drug exporter Pgp was similar in both cell lines, despite the lower drug accumulation shown by HCT-15 EDR in respect to HCT-15. Other molecules implicated in the acquisition of enhanced chemoresistance or a more active Pgp variant present in HCT-15 EDR, could explain the phenomenon.